Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis.

Jagadeswara Rao EarlaJieni LiGeorge J HuttonMichael L JohnsonRajender R Aparasu

Published in: Pharmacotherapy (2023)

TER and DMF were associated with poorer adherence trajectories than FIN. More research is needed to evaluate the clinical implications of these adherence trajectories of oral DMAs to optimize the management of MS.

Keyphrases

multiple sclerosis
depressive symptoms
mass spectrometry
glycemic control
white matter
type diabetes
ms ms
metabolic syndrome
skeletal muscle